The present application by Monsanto S.A. and Dow Agrosciences Europe (file EFSA/GMO/NL/2009/65) concerns import and processing for use in feed and food of genetically modified MON89034x1507xNK603 maize. Cultivation is not part of this application.
MON89034x1507xNK603 maize expresses the cry1A.105, cry2Ab2, cry1F, pat and cp4 epsps genes. As a result MON89034x1507xNK603 is resistant to certain lepidopteran insects. In addition, it is tolerant to glyphosate and glufosinate-ammonium containing herbicides.
MON89034x1507xNK603 was produced by conventional cross-breeding of three genetically modified parental lines. Previously, COGEM advised positively on import and processing of parental line MON89034. In addition, COGEM issued positive advices on import, processing and cultivation of 1507, NK603 and hybrid 1507xNK603.
The molecular characterization of MON89034x1507xNK603 and its individual parental lines meets the criteria of COGEM.
During its long domestication process, maize has lost its ability to survive in the wild. In the Netherlands, the appearance of maize volunteers is rare and establishment of volunteers in the wild has never been reported. There are no reasons to assume that the introduced traits or interactions between the transgenic proteins will increase the potential of maize to establish feral populations. The introduced genes cannot spread to closely related species since wild relatives of maize are not present in Europe.
In view of the above, COGEM is of the opinion that the risks for humans and the environment associated with import and processing of MON89034x1507xNK603 maize are negligible. A food/feed safety assessment is carried out by other organizations. With regard to the present application, COGEM accordingly abstains from advice on the potential risks of incidental consumption.